𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results

✍ Scribed by A. Ghezzi; M. P. Amato; M. Capobianco; P. Gallo; M. G. Marrosu; V. Martinelli; C. Milanese; L. Moiola; N. Milani; L. La Mantia; F. Patti; C. Pozzilli; M. Trojano; G. Comi; M. Zaffaroni; the Immunomodulatory Treatment of Early-onset MS (ITEMS) Group


Publisher
Springer Milan
Year
2007
Tongue
English
Weight
119 KB
Volume
28
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Short-term treatment with interferon-α/β
✍ M. Kariuki Njenga; Michael J. Coenen; Nannette DeCuir; Hung-Yueh Yeh; Moses Rodr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 1 views

The mechanisms by which type I interferons (IFN) reduce the rate and severity of exacerbations in multiple sclerosis are unknown. We utilized a model of multiple sclerosis to determine the extent of demyelination and remyelination in Theiler's murine encephalomyelitis virus (TMEV)infected SJL/J mice

Lymphoblastoid interferon alfa-n1 improv
✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l